Dermatologicals in Japan

 Published On: Nov, 2015 |    No of Pages: 33 |  Published By: Euromonitor | Format: PDF
Current value sales of dermatologicals grew by 2% in 2015 to reach •142.8 billion in in 2015. Hair loss treatments remained the largest category very closely followed by antipruritics, with retail value sales of •37.5 billion and •35.6 billion, respectively in 2015. Aging society, womanís empowerment in the workforce, and rising attention to oneís own appearance amongst young men all worked to drive sales of hair loss treatments. Moreover, when the revised PAL became effective in 2014, internet...

Euromonitor International's Dermatologicals in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN JAPAN

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2010-2015
Table 2 Sales of Dermatologicals by Category: % Value Growth 2010-2015
Table 3 NBO Company Shares of Dermatologicals: % Value 2011-2015
Table 4 LBN Brand Shares of Dermatologicals: % Value 2012-2015
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2012-2015
Table 6 Forecast Sales of Dermatologicals by Category: Value 2015-2020
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2015-2020
Daiichi Sankyo Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Competitive Positioning
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2015
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 4 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 5 Taisho Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
Summary 6 Taisho Pharmaceutical Co Ltd: Competitive Position 2015
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 7 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 8 Takeda Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
Summary 9 Takeda Pharmaceutical Co Ltd: Competitive Position 2015
Executive Summary
Modest Positive Growth Continues
Demographic Transition Increases Necessity of Self-medication
Consumer Preference of Choosing Healthcare Products Diversifies
Self-medication Movement May Change the Role of Chemists/pharmacies and Drugstores/parapharmacies.
Slow Yet Positive Value Performance Expected Over the Forecast Period
Key Trends and Developments
Japanese Government Accelerates Promotion of Self-medication To Deal With Medical Expense Caused by Aging Society.
Premiumised Products From Major Brands Lead the Market, Whilst Private Label Supports Price-conscious Segment
Remarkable Number of Inbound Tourists Enjoys Shopping in Drugstores/parapharmacies
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 9 Life Expectancy at Birth 2010-2015
Market Indicators
Table 10 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 11 Life Expectancy at Birth 2010-2015
Market Data
Table 12 Sales of Consumer Health by Category: Value 2010-2015
Table 13 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 14 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 15 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 16 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
Table 17 Distribution of Consumer Health by Format: % Value 2010-2015
Table 18 Distribution of Consumer Health by Format and Category: % Value 2015
Table 19 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 10 OTC: Switches 2013-2015
Definitions
Sources
Summary 11 Research Sources

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.